Everolimus for the second-line treatment of advanced and/or metastatic renal cell cancer: a critique of the submission from Novartis. [electronic resource]

By: Contributor(s): Producer: 20110308Description: 41-6 p. digitalISSN:
  • 2046-4924
Subject(s): Online resources: In: Health technology assessment (Winchester, England) vol. 14
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

There are no comments on this title.

to post a comment.